Atriopeptin II has been reported to cause profound coronary vasoconstriction in the isolated
perfused guinea pig heart and in the blood perfused canine heart. Consequently, this study …

The effects of atrial natriuretic peptide (ANP) on proximal epicardial coronary artery
dimensions and coronary blood flow were examined in 7 awake dogs chronically …

PREVIOUS studies have shown that a single intravenous or intracoronary bolus injection of
a-human atrial natriuretic pep—tide (ANP) causes sustained dilation of the large coronary …

Atrial natriuretic peptide has been reported to cause vasoconstriction, vasodilation or no
change of coronary vascular resistance in isolated perfused hearts or in open chest animal …

The effects of the synthetic 28-amino-acid alpha-human atrial natriuretic peptide (ANP) on
the proximal coronary arteries and coronary blood flow were evaluated in 17 patients …

Studies were performed in isolated, Langendorff-perfused rat hearts and anesthetized dogs
to determine the effects of synthetic atrial natriuretic peptide (ANP 8-33) on the coronary …

The circulating form of atrial natriuretic peptide is now believed to be composed of 28 amino
acids (1). Therefore, we studied the coronary vasoactivity of the 28 amino acid, alpha-human …

These studies were designed to define the effect of atrial natriuretic peptide (ANP) on
coronary flow. ANP was infused as a bolus directly into the left circumflex coronary artery in …

1. The effect of a alpha-human atrial natriuretic peptide (1-28)(ANP) on human vasculature
was investigated in vivo and in vitro. Possible involvement of vascular dopamine receptors …

SINCE the pioneering work by de Bold et all it has been recognized that atrial natriuretic
peptide (ANP) is released from mammalian atria and circulates as a hormone? 3 In addition …